Related Experiment Video
Updated: Jan 3, 2026

08:53
Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
Published on: March 28, 2025
722
Analysis: Particulate Limits for Intravascular Devices: Considerations for Polymer Coating Embolism
Biomedical Instrumentation & Technology
|November 26, 2019
Summary
Polymer coating particles from intravascular devices can cause embolism. This study proposes a methodology to set safe particulate limits, balancing device function and patient safety, addressing regulatory and manufacturing challenges.
Area of Science:
- Biomaterials Science
- Medical Device Engineering
- Regulatory Science
Background:
- Lubricious polymer coatings enhance intravascular device navigation but pose risks of particle embolism.
- Polymer particle embolism is an iatrogenic complication acknowledged by the FDA, necessitating improved standards for coating integrity.
- Current particulate testing standards face challenges in setting limits without compromising device function due to limited clinical data.
Purpose of the Study:
- To propose a standardized methodology for setting particulate limits for intravascular devices.
- To address clinical, regulatory, and manufacturing challenges in evaluating coating integrity.
- To enable characterization and comparison of lubricious coatings across manufacturers.
Main Methods:
- Development of a step-by-step procedure for scrutinizing coating application while ensuring device functionality.
- Incorporation of particulate assessments, clinicopathologic studies, and animal studies.
- Standardization requirements for characterizing and evaluating lubricious coatings.
Main Results:
- A proposed methodology to set particulate limits for intravascular devices is presented.
- The approach facilitates the characterization and comparison of coatings from different manufacturers.
- The methodology ensures device function is not compromised while enhancing coating integrity scrutiny.
Conclusions:
- A standardized methodology is crucial for setting particulate limits for intravascular devices.
- This approach aids in understanding particulate ranges and establishing limits for new devices.
- Balancing coating integrity, device function, and patient safety is achievable through standardized evaluation.
More Related Videos
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
254
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
254
Pulmonary Embolism I: Introduction
442
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
442
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Pulmonary Embolism III: Nursing Management
289
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
289
Venous Thrombosis I: Introduction
230
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
230
Endocarditis IV: Nursing Management
282
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
282

